Lithium, a potentially dangerous drug;Lithium, een potentieel gevaarlijk geneesmiddel

Nederlands Tijdschrift voor Geneeskunde

Volumn 149, Issue 6, 2005, Pages 273-276

  Yo, M S S ^a,b   Rommes, J H ^a   Spronk, P E ^a   Janssen, J C ^a  

^a GELRE HOSPITALS   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CASE REPORT; COMA; DIABETES INSIPIDUS; DRUG BLOOD LEVEL; DRUG INTOXICATION; FEMALE; HUMAN; HYPERPARATHYROIDISM; HYPERTHYROIDISM; HYPOTHYROIDISM; NEUROTOXICITY; PSORIASIS; SICK SINUS SYNDROME;

ADENOMA; AGED; ANTIMANIC AGENTS; BIPOLAR DISORDER; COMA; DIABETES INSIPIDUS; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; HYPERTHYROIDISM; HYPOTHYROIDISM; LITHIUM; MIDDLE AGED; PARATHYROID NEOPLASMS; PSORIASIS; SICK SINUS SYNDROME; TREATMENT OUTCOME;

EID: 13444252342     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Wilting I, Heerdink ER, Egberts ACG, Nolen WA. Elementaire behandeling van bipolaire stoornis. Therapeutische voor- en nadelen van lithium. Pharm Weekbl 2004;139:328-32.
2. Richtlijncommissie bipolaire stoornissen van de Commissie Kwaliteitszorg van de Nederlandse Vereniging voor Psychiatrie. Richtlijn Bipolaire stoornissen. Amsterdam: Boom; 2001.
3. Boton R, Gaviria M, Batlle DC. Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy. Am J Kidney Dis 1987;10:329-45.
4. Rose BD, Post TW, editors. Clinical physiology of acid-base and electrolyte disorders. New York: McGraw-Hill; 2001. p. 746-93.
5. Perrild H, Hegedus L, Baastrup PC, Kayser L, Kastberg S. Thyroid function and ultrasonically determined thyroid size in patients receiving long-term lithium treatment. Am J Psychiatry 1990;147:1518-21.
6. Johnston AM, Eagles JM. Lithium-associated clinical hypothyroidism. Prevalence and risk factors. Br J Psychiatry 1999;175:336-9.
7. Barclay ML, Brownlie BE, Turner JG, Wells JE. Lithium associated thyrotoxicosis: a report of 14 cases, with statistical analysis of incidence. Clin Endocrinol (Oxf) 1994;40:759-64.
8. Nordenstrom J, Strigard K, Perbeck L, Willems J, Bagedahl-Strindlund M, Linder J. Hyperparathyroidism associated with treatment of manic-depressive disorders by lithium. Eur J Surg 1992;158:207-11.
9. Wolf ME, Moffat M, Ranade V, Somberg JC, Lehrer E, Mosnaim AD. Lithium, hypercalcemia, and arrhythmia. J Clin Psychopharmacol 1998;18:420-3.
10. Johnson FN, editor. Handbook of lithiumtherapy. Lancaster: MTP Press; 1980. p. 310-22.
11. Abdullah H, Bliss R, Guinea AI, Delbridge L. Pathology and outcome of surgical treatment for lithium-associated hyperparathyroidism. Br J Surg 1999;86:91-3.
12. Amdisen A. Clinical features and management of lithium poisoning. Med Toxicol Adverse Drug Exp 1988;3:18-32.
13. Dunner DL. Optimizing lithium treatment. J Clin Psychiatry 2000; 61 Suppl 9:76-81.
14. Price LH, Heninger GR. Lithium in the treatment of mood disorders. N Engl J Med 1994;331:591-8.
15. Rosenqvist M, Bergfeldt L, Aili H, Mathe AA. Sinus node dysfunction during long-term lithium treatment. Br Heart J 1993;70:371-5.
16. Montalescot G, Levy Y, Hatt PY. Serious sinus node dysfunction caused by therapeutic doses of lithium. Int J Cardiol 1984;5:94-6.
17. Yeung CK, Chan HH. Cutaneous adverse effects of lithium: epidemiology and management. Am J Clin Dermatol 2004;5:3-8.